Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease

27 Feb 2018

Abstract excerpt

Impulse control disorders (ICDs) are frequent non-motor symptoms in Parkinson’s disease (PD), with potential negative effects on quality of life and social functioning. ICDs are closely associated with dopaminergic therapy, and genetic polymorphisms in several neurotransmitter pathways may increase the risk of addictive behaviors in PD. However, clinical differentiation between patients at risk and patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological disorders and treatments
Share to Neurotransmitter Receptor Influence on Behavior
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29541058
DOI: 10.3389/fneur.2018.00109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s DiseasePMID 29541058Read ↗

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.Semantic proximity Read ↗

Genetic prediction of impulse control disorders in Parkinson's diseaseSemantic proximity Read ↗

Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease.Semantic proximity Read ↗

Prediction of impulse control disorders in Parkinson’s disease: a longitudinal machine learning studySemantic proximity Read ↗

Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease.Semantic proximity Read ↗

Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors.Semantic proximity Read ↗

Current Data on the Genetic Background of Impulse Control Disorders in Parkinson’s DiseaseSemantic proximity Read ↗

Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.Semantic proximity Read ↗

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.Semantic proximity Read ↗

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.Semantic proximity Read ↗

DRD4 Gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease.Semantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.